MEDIUMClinicalTier 1
Antihistamines in atopic dermatitis
SourceAmerican Dental AssociationTier 1Hard News
Originally at news.google.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Oral antihistamines show no meaningful benefit for atopic dermatitis severity or itch, yet first-generation agents raise cognitive-impairment risk; dental teams prescribing or counseling on these drugs for skin conditions should weigh the added liability.
Key points
- Systematic review of Medline, Embase, CENTRAL, FDA and EMA data found first- and second-generation H1 antihistamines produced only small, clinically insignificant changes in atopic dermatitis severity and itch versus placebo.
- First-generation antihistamines and some second-generation agents increased risk of cognitive impairment in the more than 6,000 pediatric and adult patients analyzed.
- No antihistamine class reduced sleep disturbance or atopic dermatitis exacerbations.
- Investigators recommend against routine use of antihistamines for atopic dermatitis and hope results will inform future guideline updates.
Who should care
AssociateSpecialistAcademia
Read the original on ADA News
Full reporting and any paywall content live on news.google.com. We summarize and score; we do not republish.